Screener
Prime Medicine PRME Net gains (losses) on investments
Net gains (losses) on investments at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInEquitySecuritiesFvNi.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
FAQ
- What is Prime Medicine's net gains (losses) on investments?
- Prime Medicine (PRME) reported net gains (losses) on investments of $0 in Q2 2026.
- How has Prime Medicine's net gains (losses) on investments changed year-over-year?
- Prime Medicine's net gains (losses) on investments increased by 100.0% year-over-year, from -$505K to $0.
- What does net gains (losses) on investments mean?
- Realized and unrealized gains/losses on investments removed from operating cash flow since they're investing-related.
Ask your AI about Prime Medicine's net gains (losses) on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude